GlassScriptPhysician profile
Lisa Grinnell
NPI 1710549100
$1,264.06
in general payments reported to CMS, 2019-2025
10 companies · $985 in 2025
The $985 reported for 2025 was more than what 88% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $18.32 · 2022: $63.65 · 2024: $197 · 2025: $985.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,182.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $609.72 | 2024-2025 | Azstarys |
| Tris Pharma INC | $286.51 | 2025 | Dyanavel Xr, Quillichew Er, Quillivant |
| Supernus Pharmaceuticals, INC. | $80.59 | 2025 | Qelbree |
| Collegium Pharmaceutical, INC. | $80.12 | 2025 | Jornay Pm |
| Hologic Sales and Service, LLC | $72.50 | 2022-2025 | Novasure, Myosure Tissue Removal Device, Fluent Fluid Management System |
| Ironshore Pharmaceuticals INC. | $47.95 | 2024 | |
| Abbvie INC. | $27.05 | 2022 | |
| Neos Therapeutics, LP | $21.65 | 2025 | Adzenys Xr-Odt |
| Vertical Pharmaceuticals, LLC | $19.65 | 2025 | Relexxii |
| Organon LLC | $18.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Grinnell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.